Recon: Marks says Kennedy’s team sought ‘nonexistent’ data on vaccines; Novo to invest $1.09B to increase Ozempic, Wegovy production in Brazil
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States